InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,303.27
(
0.12%
)
US TECH 100
18,062.00
(
-0.10%
)
Dow Jones
40,003.59
(
0.34%
)
Brent Oil
83.76
(
0.00%
)
Bitcoin
66,970.82
(
-0.16%
)
Post# of 64598
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Covid19freak

Send PM Follow Ignore
Followers 10
Posts 1249
Boards Moderated 0
Alias Born 07/20/2020

Covid19freak

Re: None

Thursday, 03/07/2024 8:30:00 AM

Thursday, March 07, 2024 8:30:00 AM

Post# of 64598
TCON 0.18 - MC $6 m- Cancer drug with final data readout in Q3 and potential FDA approval by next year .. more efficacy data readout expcted this month if positive this stock likely going through the roof .

https://finance.yahoo.com/news/tracon-pharmaceuticals-reports-fourth-quarter-210200434.html

Upcoming milestones:

Complete accrual of the ENVASARC pivotal trial this quarter and report updated response rate data shortly thereafter and before the end of the quarter.

Report final data from ENVASARC pivotal trial in the second half of 2024.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up